| Schedule of Dilutive Securities, Including the Convertible Debenture and Warrants |
For the three and nine months
ended March 31, 2026 and 2025, all potentially dilutive securities, including the convertible debenture and warrants, were excluded from
the calculation of diluted loss per share because the Company was in a loss position. Their inclusion would have been antidilutive.
| | |
Nine Months Ended
March 31, | | |
Three Months Ended
March 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Net loss from continuing operations | |
$ | (3,452,877 | ) | |
$ | (1,529,602 | ) | |
$ | (1,528,811 | ) | |
$ | (376,960 | ) |
| Net income (loss) from discontinued operation | |
| 654,388 | | |
| (2,823,421 | ) | |
| 1,671,219 | | |
| (693,836 | ) |
| Net (loss) income attributable to the Company | |
$ | (2,798,489 | ) | |
$ | (4,353,023 | ) | |
$ | 142,408 | | |
$ | (1,070,796 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Weighted average number of common shares outstanding – Basic and Diluted | |
| 22,826,266 | | |
| 7,500,000 | | |
| 34,427,559 | | |
| 7,500,000 | |
| | |
| | | |
| | | |
| | | |
| | |
| Basic and Diluted Net Income (Loss) per Common Share | |
| | | |
| | | |
| | | |
| | |
| Continuing operations | |
$ | (0.15 | ) | |
$ | (0.20 | ) | |
$ | (0.04 | ) | |
$ | (0.05 | ) |
| Discontinued operations, net of tax | |
$ | 0.03 | | |
$ | (0.38 | ) | |
$ | 0.05 | | |
$ | (0.09 | ) |
| Total Basis and diluted earnings (loss) per share attributable to the Company | |
$ | (0.12 | ) | |
$ | (0.58 | ) | |
$ | 0.01 | | |
$ | (0.14 | ) |
|